Peer-to-peer review: what actually happens on the call — one year on

Peer-to-peer review: what actually happens on the call — one year on — setting out what I have, and where I think it stops being reliable.

The question about Peer-to-peer review that I actually want answered is the second one below. The first is context and I have kept it short.

Both are stated with units, and I have said what I already checked so that nobody repeats it.

The arithmetic in the opening post is right; the assumption feeding it is the part to check.

A peer-to-peer review is available in many systems and is frequently more productive than a written appeal, because it is a conversation with somebody who can decide.

I would be interested in a counterexample if anyone has one.

Where I part company with the opening post, and it is a narrow parting.

Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves frustration.

Anyone who has looked at this more carefully, please correct the record.

A well-written denial is genuinely useful because it tells you exactly what to submit next. A vague one is the harder case.

That has held every time I have looked, which is not the same as always.

Everything in post #3 holds. The case it does not cover is the one I have.

A clinician's supporting letter that addresses the criteria explicitly is worth considerably more than one that describes the patient generally.

The honest answer is that it depends, and here is what it depends on.

Nothing to add on the substance. Thank you for taking the question at face value.

Keep every document with dates in one place. An appeal months later is assembled from whatever you kept.